Northstar Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $341K | Sell |
4,880
-184
| -4% | -$12.9K | 0.05% | 117 |
|
2025
Q1 | $372K | Sell |
5,064
-502
| -9% | -$36.9K | 0.06% | 110 |
|
2024
Q4 | $365K | Hold |
5,566
| – | – | 0.06% | 108 |
|
2024
Q3 | $434K | Sell |
5,566
-175
| -3% | -$13.6K | 0.08% | 97 |
|
2024
Q2 | $448K | Hold |
5,741
| – | – | 0.08% | 90 |
|
2024
Q1 | $389K | Hold |
5,741
| – | – | 0.08% | 104 |
|
2023
Q4 | $387K | Sell |
5,741
-1,021
| -15% | -$68.8K | 0.08% | 98 |
|
2023
Q3 | $458K | Hold |
6,762
| – | – | 0.11% | 90 |
|
2023
Q2 | $484K | Buy |
6,762
+117
| +2% | +$8.37K | 0.11% | 89 |
|
2023
Q1 | $461K | Hold |
6,645
| – | – | 0.12% | 90 |
|
2022
Q4 | $451K | Hold |
6,645
| – | – | 0.13% | 90 |
|
2022
Q3 | $364K | Hold |
6,645
| – | – | 0.11% | 101 |
|
2022
Q2 | $439K | Hold |
6,645
| – | – | 0.13% | 93 |
|
2022
Q1 | $441K | Hold |
6,645
| – | – | 0.11% | 101 |
|
2021
Q4 | $387K | Buy |
+6,645
| New | +$387K | 0.09% | 109 |
|